Login

IMJUDO 20 mg/ml concentrate for solution for infusion

*
Pharmacy Only: Prescription

  • Company:

    AstraZeneca Pharmaceuticals (Ireland) DAC

  • Status:

    No Recent Update

  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)

  • Active Ingredient(s):

    Tremelimumab

    This medicinal product is subject to additional monitoring.

    *Additional information is available within the SPC or upon request to the company

Licence number Strength ATC code Dosage form EU/1/22/1713/001 25 mg L01FX20 Concentrate for solution for infusion EU/1/22/1713/002 300 mg L01FX20 Concentrate for solution for infusion